Repligen (RGEN) net assets (shareholders' equity)

Net assets · fiscal 2025
$2.11B

Repligen (RGEN) had net assets of $2.11B at the end of fiscal 2025 (December 31, 2025). That is 6.8% higher than the $1.97B of fiscal 2024. Figures as of 18 Nov 2026, 23:55 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$2.11B
Change on fiscal 2024
+6.8%
Growth, 5 years
+6.6% a year
Growth, 10 years
+32.9% a year
Highest on record
$2.11Bfiscal 2025
Lowest on record
$65.99Mfiscal 2011
Fiscal years on record
172010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Repligen net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 6.6% a year; over ten years the rate was 32.9% a year. Across the 17 fiscal years on record (2010–2025), the highest was $2.11B in fiscal 2025 and the lowest $65.99M in fiscal 2011.

History · 17 fiscal years

Net assets by fiscal year

Repligen net assets (shareholders' equity), year by year

Repligen (RGEN) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$2.11B 6.8% up
2024$1.97B 0.4% up
2023$1.96B 2.8% up
2022$1.91B 9.2% up
2021$1.75B 14.4% up
2020$1.53B 44.3% up
2019$1.06B 72.2% up
2018$615.57M 4.1% up
2017$591.55M 250.5% up
2016$168.76M 37.5% up
2015$122.75M 9.9% up
2014$111.73M 32.8% up
2013$84.12M 0.0%
2012$84.12M 27.5% up
2011$65.99M—
2011$67.09M 1.5% up
2010$66.12M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Repligen and comparable companies
CompanyNet assetsFiscal year
Kymera Therapeutics KYMR$1.58B2025
DaVita DVA-$651.08M2025
Halozyme Therapeutics HALO$48.81M2025
Universal Health Services UHS$7.28B2025
Repligen RGEN$2.11B2025
Bio-Techne TECH$2.11B2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RGEN

Repligen, figure by figure

Repligen (RGEN) overview: price, valuation and scorecardAll health care companies by market value

Repligen net assets (shareholders' equity): questions and answers

What are Repligen's net assets?

Repligen (RGEN) had net assets of $2.11B at the end of fiscal 2025 (December 31, 2025). That is 6.8% higher than the $1.97B of fiscal 2024.

What is the growth rate of Repligen's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 6.6% a year; over ten years the rate was 32.9% a year.

What are the highest and lowest net assets figures on record for Repligen?

Across the 17 fiscal years on record (2010–2025), the highest was $2.11B in fiscal 2025 and the lowest $65.99M in fiscal 2011.

How is Repligen's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Repligen it is on record here for 17 fiscal years, 2010 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Repligen (RGEN) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/RGEN/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.